Thirty students are underway with a new Graduate Entry Medical course at the University of East Anglia (UEA)
By: Communications
Thirty students are underway with a new Graduate Entry Medical course at the University of East Anglia (UEA).
Bringing in graduates from a range of disciplines, the new four-year course is one year shorter than a standard medical degree course without compromising on quality.
The programme has been developed to help meet current and future NHS workforce demands, particularly aimed at providing the skills to serve our region’s rural and coastal communities.
Prof Philip Baker, Pro-Vice-Chancellor for the Faculty of Medicine and Health Sciences at UEA, said: “We’re delighted to welcome the first cohort of students onto this innovative new course. It provides a unique opportunity for local graduates from a range of different routes to undergo training locally and to benefit from the excellent teaching and facilities at Norwich Medical School and with our partners.”
Medical students will have access to state-of-the-art facilities at the James Paget University Hospital, the Queen Elizabeth Hospital King’s Lynn NH Foundation Trust and the Norfolk and Norwich University Hospital.
Related Articles
Scientists uncover genetic fingerprints linked to aggressive prostate cancer
Scientists have uncovered new clues that could help identify which prostate cancers are most likely to spread, and which are less likely to become life-threatening, in the first major findings from an international project co-founded by UEA.
Read more
Cancer drug could help millions battling osteoporosis and mid-life weight gain
An experimental cancer drug could stop osteoporosis and help women stay slim after the menopause – according to new research from the University of East Anglia.
Read more
New UEA spinout Nascent Therapeutics secures investment to advance revolutionary treatment for age-related conditions
A spinout company from the University of East Anglia (UEA) is developing a revolutionary new approach to treating neurodegenerative diseases, cancer, and other age-related conditions.
Read more